Skip to main content

Table 1 Typical schedule for a patient enrolled in the CLEM protocol: summary of different stages

From: Study protocol on Alzheimer’s disease and related disorders: focus on clinical and imaging predictive markers in co-existing lesions

  Baseline Month 6 Month 12 Month 18 Month 24
Consent     
 Inclusion/non inclusion criteria     
 Medical history or event
 Clinical examination
 CDR    
 DAD
 IADL
 MMSE    
 Neuropsychological diagnosis testing     
 ADAS-Cog/BREF    
 NPI
 Medication
 Blood sampling     
 Neurobiotec Biobank     
 MRI     
 SPECT-DaTscan®     
 Amyloid PET     
 LP (optional)